Hagen, PT, Scholz, DG, Edwards, WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc
1984; 59: 17–20.
Kenny, D, Turner, M, Martin, R. When to close a patent foramen ovale. Arch Dis Child
2008; 93: 255–259.
Lechat, P, Mas, JL, Lascault, G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med
1988; 318: 1148–1152.
Webster, MW, Chancellor, AM, Smith, HJ, et al. Patent foramen ovale in young stroke patients. Lancet
1988; 2: 11–12.
Del Sette, M, Angeli, S, Leandri, M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis
1998; 8: 327–330.
McCandless, RT, Arrington, CB, Nielsen, DC, Bale, JF Jr, Minich, LL. Patent foramen ovale in children with migraine headaches. J Pediatr
2011; 159: 243–247.
Choi, DY, Shin, DH, Cho, KH, Lee, SP, Park, S. Migraine with aura: a predictor of patent foramen ovale in children and adolescents. Cephalalgia
2013; 33: 463–468.
Perkovič-Benedik, M, Zaletel, M, Pečarič-Meglič, N, Podnar, T. A right-to-left shunt and prothrombotic disorders in pediatric patients presenting with transient ischemic attack. Eur J Pediatr
2013; 172: 239–245.
Agnetti, A, Carano, N, Sani, E, et al. Cryptogenic stroke in children: possible role of patent foramen ovale. Neuropediatrics
2006; 37: 53–56.
Benedik, MP, Zaletel, M, Meglic, NP, Podnar, T. A right-to-left shunt in children with arterial ischaemic stroke. Arch Dis Child
2011; 96: 461–467.
Cujec, B, Mainra, R, Johnson, DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol
1999; 15: 57–64.
Orgera, MA, O’Malley, PG, Taylor, AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J
2001; 94: 699–703.
Butera, G, Bini, MR, Chessa, M, Bedogni, F, Onofri, M, Carminati, M. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J
2001; 2: 115–118.
Schwerzmann, M, Wiher, S, Nedeltchev, K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology
2004; 62: 1399–1401.
Davis, D, Gregson, J, Willeit, P, Stephan, B, Al-Shahi Salman, R, Brayne, C. Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology
2013; 40: 56–67.
Garg, P, Servoss, SJ, Wu, JC, et al. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation
2010; 121: 1406–1412.
Bartz, PJ, Cetta, F, Cabalka, AK, et al. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovaledevice closure. Mayo Clin Proc
2006; 81: 615–618.
Menon, SC, Grove, A, McFadden, M, Korgenski, KE, Cowley, CG. Clinical practice, resource utilization, and outcomes of device closure of patent foramen ovale in pediatrics. Pediatr Neurol
2014; 50: 213–217.